+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Dermatological manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome in era of highly active antiretroviral therapy



Dermatological manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome in era of highly active antiretroviral therapy



Indian Journal of Sexually Transmitted Diseases and Aids 35(1): 73-75




(PDF emailed within 0-6 h: $19.90)

Accession: 052497873

Download citation: RISBibTeXText

PMID: 24958996

DOI: 10.4103/0253-7184.132412



Related references

Oral manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome and their correlation to cluster of differentiation lymphocyte count in population of North-East India in highly active antiretroviral therapy era. Contemporary Clinical Dentistry 7(4): 539-543, 2016

Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome. Indian Journal of Ophthalmology 56(5): 391-393, 2008

Impact of highly active antiretroviral therapy on oral manifestations of patients with human immunodeficiency virus/acquired immuno deficiency syndrome in South India. Indian Journal of Sexually Transmitted Diseases and Aids 36(1): 35-39, 2015

Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. Journal of Nephrology 14(5): 377-383, 2001

A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy. Transplantation Proceedings 40(8): 2677-2679, 2008

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. Journal of Neurovirology 10(6): 350-357, 2005

Prospective cohort study of children born to human immunodeficiency virus-infected mothers, 1985 through 1997: trends in the risk of vertical transmission, mortality and acquired immunodeficiency syndrome indicator diseases in the era before highly active antiretroviral therapy. Pediatric Infectious Disease Journal 19(7): 618-624, 2000

Dermatological aspects of medicine: highly active antiretroviral therapy and the treatment of human immunodeficiency virus. Clinical and Experimental Dermatology 35(1): 107-109, 2010

Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatric Infectious Disease Journal 30(1): 45-51, 2011

The physical activity levels among people living with human immunodeficiency virus/acquired immunodeficiency syndrome receiving high active antiretroviral therapy in Rwanda. Sahara J 10(3-4): 113-118, 2015

Dermatological manifestations of human immunodeficiency virus infected / acquired immunodeficiency syndrome patients in a referral hospital of Central Kerala. Indian Journal of Dermatology, Venereology and Leprology 61(2): 89-90, 1995

The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy. Journal of Neurovirology 11(2): 180-189, 2005

Ophthalmic manifestations of human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Archives of Ophthalmology 130(12): 1621-1623, 2014

Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era. Journal of Oral Pathology and Medicine 38(8): 613-622, 2009

Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy. Lijecnicki Vjesnik 127(5-6): 123-128, 2005